By Mauro Orru 
 

Roche Holding AG said Thursday that the U.S. Food and Drug Administration has issued an emergency use authorization for its Elecsys IL-6 test, which helps identify severe inflammatory response in patients with confirmed Covid-19.

The Swiss drugmaker said the decision makes the in vitro diagnostic test accessible to patients in the United States and is also available in markets accepting the CE mark.

Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94

(END) Dow Jones Newswires

June 04, 2020 01:30 ET (05:30 GMT)